Far di Necessità Virtù, using rare tubulopathies, Gitelman's and Bartter's syndromes, to inform the fight against COVID-19.

Calò, Lorenzo A; Davis, Paul A

Calò, Lorenzo A; Davis, Paul A.

Calò LA; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, DIMED, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. renzcalo@unipd.it.
Davis PA; Department of Nutrition, University of California, Davis, USA.

J Nephrol ; 34(2): 281-283, 2021 04.

Article in English | MEDLINE | ID: covidwho-1009232

Subject(s)

Bartter Syndrome/epidemiology; COVID-19/epidemiology; Disease Management; Gitelman Syndrome/epidemiology; Pandemics; SARS-CoV-2; Bartter Syndrome/therapy; COVID-19/therapy; Comorbidity; Gitelman Syndrome/therapy; Humans; Italy/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bartter Syndrome / Disease Management / Gitelman Syndrome / Pandemics / SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Europa Language: English Journal: J Nephrol Journal subject: Nephrology Year: 2021 Document Type: Article Affiliation country: S40620-020-00951-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google